News
CAH
96.91
+0.21%
0.20
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Cardinal Health has outperformed the market over the past 5 years by 3.59% on an annualized basis. If an investor bought $1000 of CAH stock 5 years ago, it would be worth $2,154.67 today. Cardinal Health has an average annual return of 16.28%.
Benzinga · 7h ago
Why the Market Dipped But Cardinal Health (CAH) Gained Today
NASDAQ · 3d ago
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
NASDAQ · 3d ago
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast, visit Cardinal Health's Investor Relations page.
PR Newswire · 3d ago
Weekly Report: what happened at CAH last week (0715-0719)?
Weekly Report · 4d ago
Cardinal Health Is Maintained at Neutral by Citigroup
Dow Jones · 07/19 19:42
Cardinal Health Price Target Cut to $107.00/Share From $115.00 by Citigroup
Dow Jones · 07/19 19:42
Citigroup Maintains Neutral on Cardinal Health, Lowers Price Target to $107
Benzinga · 07/19 19:33
Interesting CAH Put And Call Options For March 2025
NASDAQ · 07/18 14:42
Cardinal Health: Navigating Inflation with Strategic Mitigation – Outperform Rating & $122 Target
TipRanks · 07/18 06:46
McKesson, Cardinal, Cencora interested in buying private cancer clinics - report
Seeking Alpha · 07/17 21:51
Insiders At Cardinal Health Sold US$9.7m In Stock, Alluding To Potential Weakness
Cardinal Health, Inc. Insiders have sold US$3.5m worth of shares in the last year. The biggest sale was by the Chief Legal & Compliance Officer of the company, Jessica Mayer, for US$90.84 per share. Cardinal Health insiders didn't buy any stock in the past year. But the company does have a high level of insider ownership. You can see the insider transactions of Cardinal Health over the lastyear.
Simply Wall St · 07/17 14:31
How Is The Market Feeling About Cardinal Health?
Cardinal Health's short percent of float has fallen 17.69% since its last report. The company has 6.12 million shares sold short, which is 3.35% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 07/16 14:15
Weekly Report: what happened at CAH last week (0708-0712)?
Weekly Report · 07/15 09:17
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
NASDAQ · 07/12 16:08
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
NASDAQ · 07/11 11:00
Analysts Conflicted on These Healthcare Names: Cardinal Health (CAH) and Apellis Pharmaceuticals (APLS)
TipRanks · 07/11 10:50
Cardinal Health Price Target Cut to $105.00/Share From $115.00 by Evercore ISI Group
Dow Jones · 07/09 15:13
Cardinal Health Is Maintained at In-Line by Evercore ISI Group
Dow Jones · 07/09 15:13
Evercore ISI Group Maintains In-Line on Cardinal Health, Lowers Price Target to $105
Benzinga · 07/09 15:03
More
Webull provides a variety of real-time CAH stock news. You can receive the latest news about Cardinal Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About CAH
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions (PSS) and Global Medical Products and Distribution (GMPD). The PSS segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It also offers Olathe medical devices.